Abstract Submissions

Abstract submission deadline: October 1, 2023
All submitted abstracts become the property of MDS.
All accepted abstracts are published by MDS.
An individual may be the first author on a maximum of three (3) abstracts.
An individual may be a contributing author on an unlimited number of abstracts.
 
MDS Members and non-members are welcome to submit abstracts.
There is no fee to submit an abstract.
Abstract presenters are encouraged to attend the PAS Congress to present their abstract in person. In-person abstract presenters are required to register for the PAS Congress and pay applicable registration fees.
 
Abstracts must be submitted in their final form on October 1, 2023. Requests to edit abstract data and/or outcomes after the submission deadline will not be granted. All other abstract edits are not guaranteed.

All accepted abstracts will be published in an electronic supplement to the Movement Disorders Clinical Practice journal, online edition. All submitted abstracts become the property of MDS.
 
All accepted abstracts will be presented as a printed poster during designated times of the 5th PAS Congress.

Daily poster presentations will be scheduled Friday and Saturday during the 5th PAS Congress. A detailed schedule, including poster set up and removal times, will be included in the abstract acceptance notification for each poster.

Note: Accepted abstract presenters should plan to attend the 5th PAS Congress for the duration of the meeting, from February 9-11, 2024, as poster presentation dates are subject to change.
 
All abstract presenters are required to register and pay applicable registration fees to attend the 5th PAS Congress. It is not mandatory that the first author is pre-registered; the presenter can be any of the contributing authors or a colleague.

MDS only accepts original work. By submitting your abstract, you affirm that your abstract is your own, either individually or as a group. Should plagiarism be detected, the abstract will be rejected.

Abstracts that have been presented at other meetings may be submitted if they have not been previously published. Submitted abstracts that have been presented at other meetings must include the previous meeting name and presentation date cited accordingly in the abstract body, after the Conclusion.

Abstracts that have been previously published will not be accepted by MDS.

If the abstract submission is scheduled for publication after the submission deadline but prior to the MDS publication date, February 9, 2024, then the abstract must be withdrawn.

MDS does not accept abstracts that have been previously published by MDS (encore abstracts).

If the abstract is found to have been previously published in another MDS publication or a previous edition of the Movement Disorders journal, the designated contact person will be notified and the abstract will be rejected.

All abstracts presented at a previous MDS International Congress or MDS Regional Congress (PAS Congress or AOPMC) have been published by MDS.

Edits to abstracts after submitting are highly discouraged.
If edits to a submitted abstract are required, login to the online submission portal, https://catalyst.omnipress.com, and edit as needed. Click “submit” when you are finished. All edits must be submitted by the abstract submission deadline, October 1, 2023.
 
June 1, 2023 – October 1, 2023
You may withdraw a submitted abstract at any time while submission is still open (before October 1, 2023). To withdraw an abstract, simply log in to your submission and click on 'Withdraw'. There is no penalty to withdraw your abstract.

October 1, 2023 – December 1, 2023
Requests to withdraw a submitted abstract after the submission deadline (October 1, 2023) must be received in writing by December 1, 2023, to pascongress@movementdisorders.org

December 1, 2023 – Onward
After December 1, 2023, your abstract cannot be withdrawn and will remain a part of the 2024 PAS Congress abstract publication in an electronic supplement to the Movement Disorders Clinical Practice journal, online edition. All submitted abstracts become the property of MDS.

Text limit of 2,500 characters (including spaces) for the body of the abstract. The size limit includes characters and spaces in the Abstract Title and Abstract Body. Please note that spaces are included in the overall character count. The size limit does not include author information or reference sections.

Abstracts should be arranged as follows:

• Objective
• Background
• Methods
• Results
• Conclusions

*You may submit a case report using the standard abstract format

When compiling your submission please take note of the following:

• Do not include any identifying information directly on the abstract.
• Do not include branded product names in the abstract. If the abstract is found to contain marketing, rather than scientific content, the abstract will be rejected.
• Only nonproprietary (generic) drug names should be used and should be written without capitals.
• Select one (1) category under which the abstract should be reviewed. If the abstract covers more than one topic, please choose the most appropriate category.
  • If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by International Congress attendees as well as online researchers.
• The use of standard abbreviations is desirable. A special or unusual abbreviation should be placed in parentheses after the first appearance of the full word for which it stands.

Please note there is a separate upload field for tables and graphs. To include tables, graphs, or images, enter the appropriate ID tag within the abstract body where the tables and/or figures should appear. Tags must be entered as shown - [table1] for your first table; [table2] for your second table; [figure1] for your first figure; [figure2] for your second figure.

To list references, enter the appropriate ID tag. [1] for your first reference, [2] for your second reference, [3] for your third reference, etc.

The PAS Congress Scientific Program Committee will review all abstracts in October of 2023. The Committee shall be directed to reject abstracts for the following reasons:

• Plagiarism detected
• Marketing detected
• Subject not related to the field of Movement Disorders
• Does not meet basic requirements

All submitted abstracts will undergo plagiarism review through an online plagiarism detection software. Should plagiarism be detected, the abstract will be rejected.

If it is determined by the PAS Congress Scientific Program Committee that a submitted abstract is not entered in the optimal abstract category listing, MDS reserves the right to re-categorize the abstract on behalf of the author(s) without prior notification. The new category placement will be confirmed in the official abstract notification letter. If it is determined that the abstract should be re-categorized, MDS will ensure that the new category placement is in the best interest of the work and easily searchable by PAS Congress attendees as well as online researchers.

All abstract notification e-mail and correspondence will be communicated to the designated contact person of the abstract; identified as ‘Contact for Official Abstract Correspondence’ on the official submission form. Abstract acceptance notifications will be sent to the designated contact person via e-mail in early November 2023.
 
All submitted abstracts will receive a confirmation e-mail to the designated contact person.

If the confirmation e-mail has not been received within 24-hours of submitting the abstract, please log in to the abstract submission site, https://catalyst.omnipress.com, to verify the status of the submission.
 
After abstract notifications have been sent via e-mail, an official abstract notification letter will be available through the submission site and can be downloaded and printed at any time.
 
All confirmed abstract submissions will be reviewed for acceptance by MDS.
Abstracts with a status of ‘saved’ are not confirmed submissions and will not be reviewed by MDS.
 
Please ensure that noreply@omnipress.com and pascongress@movementdisorders.org are designated as a “safe senders” to ensure timely correspondence regarding the abstract submission.

Please check your spam and junk e-mail folders before contacting MDS regarding the status of your abstract. Abstract notices will be sent from noreply@omnipress.com. Abstract status can also be checked directly on the submission site in November 2023.

June 1, 2023 – October 1, 2023
You may withdraw a submitted abstract at any time while submission is still open (before October 1, 2023). To withdraw an abstract, simply log in to your submission and click on 'Withdraw'. There is no penalty to withdraw your abstract.

October 1, 2023 – December 1, 2023
Requests to withdraw a submitted abstract after the submission deadline (October 1, 2023) must be received in writing by December 1, 2023, to pascongress@movementdisorders.org

December 1, 2023 – Onward
After December 1, 2023, your abstract cannot be withdrawn and will remain a part of the 2024 PAS Congress abstract publication in an electronic supplement to the Movement Disorders Clinical Practice journal, online edition. All submitted abstracts become the property of MDS.